The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics

@article{Flowers2004TheRO,
  title={The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics},
  author={Christopher R Flowers and David L. Veenstra},
  journal={PharmacoEconomics},
  year={2004},
  volume={22},
  pages={481-493}
}
The broad availability of genetic information and technologies heralds an era when practitioners will utilise genomic testing to individualise patients’ care. Pharmacogenomics uses a spectrum of approaches to explore the association of genetic variation with drug efficacy or toxicity. Investigators have described a broad array of genetic polymorphisms that confer inter-individual differences in drug response. Pharmacogenomics offers the potential to improve drug effectiveness, reduce adverse… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Gene expression data using the factors we have described as a guide . profiling predicts clinical outcome of breast cancer

  • LJ van’tVeer, H Dai, MJ vandeVijver
  • Nature
  • 2002

Recommendations of outcomes : angiotensin I - converting enzyme as an example . the Panel on Cost - Effectiveness in Health and Medicine

  • DW Moskowitz, MC Weinstein, JE Siegel, MR Gold
  • Diabetes Technol Ther
  • 2002

Guide to clinical laboratory testing [ online ]

  • SD Ramsey, SD Sullivan
  • 2000

Similar Papers

Loading similar papers…